Monday, June 24, 2013

Ex Parte Ad Interim Injunction Granted by Delhi HC Against Aprica Pharma on Sitagliptin

In an ex parte ad interim injunction order issued on June 17, 2013 in suit instituted by Merck against Aprica Pharma with respect to Sitagliptin (IN209816), the Delhi High Court has restrained Aprica from selling, distributing,  advertising, exporting, offering for sale and in any other manner, directly or indirectly, dealing in any product that infringes the subject matter of the” patent.

The next date in the matter is August 13, 2013.

Earlier in April, we had reported the denial of interim injunction with respect to the same drug against Glenmark, in which an appeal is pending before Justice Ravindra Bhat. We will keep the readers posted on the developments in the Suits and appeal.

I thank a dear friend for sharing this development with me.

5 comments:

  1. Dear JSD:

    What is confusing is that there is no discussion of the earlier Glenmark (no) injunction in the current order from the vacation batch.

    - dear friend

    ReplyDelete
  2. Dear JSD,
    Long time no post!!

    ReplyDelete
    Replies
    1. Sorry :-) Have been really tied up with a lot of work and "extra-curricular" commitments :-) will surely make up for it soon! The idea is to write on slightly different issues after a bit of reading.

      Sai.

      Delete
  3. looking forward to it:)
    I thought blogging was "extra curricular" ;)

    ReplyDelete
    Replies
    1. For me, blogging is "curricular" in a way :-)

      Delete